JUN_02
Asset
Dual-targeted siRNA designed to restore gene networks.
- Stage
- Preclinical
- Modality
- Oligonucleotide
- Target
- Lipid and ceramide metabolism
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Obesity
Preclinical, junevity.com, 10 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Evidence for its targets1
- Competitors12
Every asset’s record: target, stage, trials and the evidence behind it.